UK NEQAS Cardiac Markers

NHS Greater Glasgow & Clyde, operating UK NEQAS Cardiac Markers, is a UKAS accredited proficiency testing provider (No:8560)(BS EN ISO/IEC 17043:2010). We are a non-profit centre working within NHS Greater Glasgow and Clyde to improve cardiac biomarker investigations in the clinical laboratory sector for the benefit of patients.

Cardiac markers, especially Troponin I (cTnI) and Troponin T (cTnT), are critical measurements in acute coronary syndrome. Most authorities recommend that these measurements are carefully quality controlled. UKNEQAS Cardiac Marker schemes meet the external quality assessment (EQA) requirements of members by providing monthly distributions of samples with clinically relevant levels of these markers.

The scheme is a full member of UKNEQAS. The cardiac troponin EQA schemes have been in operation since 1998.

The following EQA schemes are UKAS accredited. However schemes with less than ten participants are outwith scope of this accreditation:

Laboratory Based Schemes: cTnI (including high sensitivity methods), hsTnT, CKMB, Myoglobin, B-type Natriuretic Peptide (BNP) and NT-proB-type Natriuretic Peptide (NT-proBNP).
Point of Care Schemes - cTnI, cTnT, CKMB, Myoglobin, and NT-proBNP.

Point of Care Scheme for BNP is no longer accredited due to small numbers of participants.

A Pilot Point of Care Scheme for hs cTnI is now available - please contact the scheme for further information

 

The 5th Cardiac Marker Dialogues meeting will take place in Glasgow on the 30th September 2022. Further information, including registration and poster submission dates, for this meeting can be found on https://www.cmdmeeting.org.uk

 

UK NEQAS Chemistry Division Webinar on Cardiac Markers, 7th July 2022 at 13:00. Registration via Birmingham Quality website.

 

UK NEQAS Cardiac Markers is operating normally.

 

Distribution 290 for July 2022:

  • Samples will be dispatched to laboratories during the week beginning 27th June 2022.
  • Data entry for this distribution opens on the 4th July 2022.
  • Final date for return of results 22nd July 2022.
  • Reports now available for distribution 289 (June 2022).

We will continue to review our dispatch dates over the next couple of months and adapt if required.

Information on customs information for EU participants is available in our news section under Customs Information

Where do you want to go?

 

Register to participate

 

General enquiry

Our Scope

Cardiac Markers

UK NEQAS Cardiac Markers is organised to provide a UK National External Quality Assessment Scheme for the assay of cardiac Troponin Iand Troponin T (including high sensitivity methods), Creatine Kinase (MB), Myoglobin, B-type Naturetic Peptide and N-Terminal -ProB-type Naturetic Peptide and will develop appropriate EQA schemes for new cardiac biomarkers. Schemes are available for both laboratory systems and for point of care systems.

 

Participation

Our schemes are open to all clinical/research laboratories in the UK and overseas. It is anticipated that the majority of participants will be UK NHS laboratories. The Scheme will accept participants from the private sector and from the diagnostics industry, within or out with theUK on the same basis (with fee adjustment) as UK laboratory participants.

Collaboration

We see it as part of the duty of an EQA scheme to give advice to participating laboratories about assay problems related to the EQA when this is asked for.  The EQA response to poor laboratory performance is separately described. We have contacts with developing cardiac Troponin EQA schemes in EU countries and elsewhere. We think it important to foster and contribute to these information links as there are substantial inter-assay calibration problems which still remain to be solved.


Register to Participate

 

If you do not participate at present and wish further information on the schemes we provide, contact us.

Latest News

Cardiac Marker Dialogues – 30th September 2022 – Glasgow, Scotland, UK.

The 5th Cardiac Marker Dialogues meeting will take place in Glasgow on the 30th September 2022. Further information, including registration and poster submission dates, for this meeting can be found on https://www.cmdmeeting.org.uk

UK NEQAS Chemistry Division – Cardiac Marker Scheme Webinar

Alan Reid will be giving a Webinar on UK NEQAS Cardiac Marker Schemes on 7th July 2022 at 13:00. Registration via the Birmingham Qualiry Website.

COVID: Distribution 284 Final date of Result Entry Changed

Due to the current effects of the COVID pandemic there may be possible delays in delivery of samples for distribution (284). For this reason, the final date of entry of results for this distribution has been extended from 28th January to 2nd February 2022.

See all our news